✦ LIBER ✦

Concurrent Bevacizumab with a Sequential Regimen of Doxorubicin and Cyclophosphamide Followed by Docetaxel and Capecitabine as Neoadjuvant Therapy for HER2− Locally Advanced Breast Cancer: A Phase II Trial of the NSABP Foundation Research Group

✍ Scribed by Priya Rastogi; Marc E. Buyse; Sandra M. Swain; Samuel A. Jacobs; André Robidoux; Marcia K. Liepman; Eduardo R. Pajon; Philip A. Dy; Juan G. Posada Jr; Marianne K. Melnik; Fanny Piette; Charles E. Geyer Jr; Elfetherios P. Mamounas; Norman Wolmark

Book ID: 113538925
Publisher: CIG Media Group, LP.
Year: 2011
Tongue: English
Weight: 570 KB
Volume: 11
Category: Article
ISSN: 1526-8209
DOI: 10.1016/j.clbc.2011.04.001

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A multicenter, phase II study of epirubi

A multicenter, phase II study of epirubicin/cyclophosphamide followed by docetaxel and concurrent trastuzumab as primary systemic therapy for HER-2 positive advanced breast cancer (the HER2NAT study)

✍ Aogi, Kenjiro; Saeki, Toshiaki; Nakamura, Seigo; Kashiwaba, Masahiro; Sato, Nobu 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 329 KB

0170 Phase II trial of neoadjuvant seque

0170 Phase II trial of neoadjuvant sequential FEC100 followed by docetaxel, carboplatin and trastuzumab (TCH) for HER-2 over-expressing locally advanced breast cancer (LABC): A multi-centre study from British Columbia

✍ S. Chia; C. Bryce; G. Pansegrau; N. Macpherson; S. Ellard; D. Jepson; C. Yu; S. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Cyclophosphamide and liposomal-encapsula

Cyclophosphamide and liposomal-encapsulated doxorubicin (MYOCET®) in elderly women with HER-2 negative locally advanced or metastatic breast cancer: Preliminary results of a multicenter phase II trial from the Hellenic Oncology Research Group

✍ Karampeazis⁎, A.; Ardavanis, A.; Kentepozidis, N.; Nikolaou, Ch.; Bozionelou, V. 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 80 KB

Radiation Therapy Oncology Group Protoco

Radiation Therapy Oncology Group Protocol 02-29: A Phase II Trial of Neoadjuvant Therapy With Concurrent Chemotherapy and Full-Dose Radiation Therapy Followed by Surgical Resection and Consolidative Therapy for Locally Advanced Non-small Cell Carcinoma of the Lung

✍ Mohan Suntharalingam; Rebecca Paulus; Martin J. Edelman; Mark Krasna; Whitney Bu 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 265 KB

P.39 Docetaxel plus epirubicin (DE) vs d

P.39 Docetaxel plus epirubicin (DE) vs docetaxel plus capecitabine (DC) as 1st line treatment in patients with locally advanced and metastatic breast cancer: a subgroup analysis for elderly patients of a multicenter randomized phase III trial from the Hellenic Oncology Research Group (HORG)

✍ Vamvakas, L.; Karampeazis, A.; Ardavanis, A.; Souglakos, I.; Kalbakis, K.; Varda 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 57 KB